Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
维奈托克和伊布替尼可诱导边缘区淋巴瘤患者产生持久的临床缓解
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025016646
Handunnetti, Sasanka M; Khot, Amit; Blombery, Piers; Burbury, Kate; Thompson, Philip A; Ritchie, David; Hicks, Rodney J; Burke, Glenda; Koldej, Rachel; Bressel, Mathias; Di Iulio, Juliana; Westerman, David A; Lade, Stephen; Roberts, Andrew W; Seymour, John F; Tam, Constantine S; Anderson, Mary Ann